Case Study: Supplying mRNA COVID 19 Vaccine at Unprecedented Pace & Scale

Here to be presented is case study on Pfizer’s journey to supplying COVID 19 Vaccine at unprecedented pace & scale. Kevin will give a high-level overview of Pfizer’s and BioNTech’s mRNA vaccine technology and bring us through us some of the key process innovations which facilitated rapid process development and scale up which were required to provide COVID 19 vaccine at a pandemic supply level.